跳至主要内容
临床试验/NCT00002336
NCT00002336已完成不适用

A Prospective, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of the Safety and Efficacy of Clarithromycin for the Prevention of Disseminated Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients With CD4 Counts <= 100 Cells/mm3

Abbott22 个研究点 分布在 1 个国家开始时间: 1992年11月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
试验地点
22

研究概览

简要总结

To determine whether clarithromycin is safe and effective in preventing disseminated Mycobacterium avium Complex in HIV-infected patients with CD4 counts <= 100 cells/mm3.

研究设计

研究类型
Interventional
主要目的
Treatment
盲法
Double

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients must have:
  • •HIV infection.
  • •CD4 count <= 100 cells/mm
  • •No evidence of MAC.
  • •Life expectancy of at least 6 months.

排除标准

  • •Concurrent Medication:
  • •Certain restricted drugs (details not available).
  • •Patients with the following prior conditions are excluded:
  • •History of allergy or hypersensitivity to macrolides. Active substance abuse or other conditions that would affect study compliance.

研究者

发起方
Abbott
申办方类型
Industry

研究点 (22)

Loading locations...

相似试验